glp-1 drug mounjaro Eli Lilly to seek approval of new weight-loss this year What Foods and Drinks Are

Grech O, Mitchell JL, Lyons HS, Yiangou A, Thaller M, Tsermoulas G, Brock K, Mollan SP, Sinclair AJ (2024) Effect of glucagon like peptide-1 receptor agonist exenatide, used as an intracranial pressure lowering agent, on cognition in idiopathic intracranial hypertension

Clinicians are Read More

More concerning but less common side effects include gallbladder problems , potential thyroid issues (a black box warning exists for medullary thyroid carcinoma risk in animal studies), and hair loss related to rapid weight loss rather than the medication itself

1:e00009

This will support more informed, anticipatory, and patient-centered care in the emergency department